Pressurised intraperitoneal aerosol chemotherapy is a new surgical technique, developed for the treatment of initially unresectable peritoneal carcinomatosis. The objective of this study was to compare the results of PIPAC associated with systemic chemotherapy with those of systemic chemotherapy alone in patients with gastric peritoneal carcinomatosis without metastasis other than peritoneal, and WHO performance status \<3.
Study Type
OBSERVATIONAL
Enrollment
46
PIPAC procedures were performed every 6 to 8 weeks, alternating with systemic chemotherapy, replacing a cycle of intravenous chemotherapy.
Intravenous chemotherapy
CHUGA
Grenoble, France
Overall survival at 6 months
Overall survival at 6 months from diagnosis of carcinomatosis
Time frame: 6 months
Duration of hospital stay
duration of hospitalization up to 6 months after the diagnosis of carcinomatosis
Time frame: 6 months
overall survival from the diagnosis of carcinomatosis and from the diagnosis of the primary tumour.
overall survival throughout the study follow-up from the diagnosis of carcinomatosis and from the diagnosis of the primary tumour.
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.